Imaging for NAFLD and NASH Studies
BioTel Research provides expert imaging solutions for clinical trials researching liver therapies. As a leader in imaging based quantification of hepatic fat, we strengthen your trial with unparalleled experience and global operational support.
62
liver studies
700
study sites
5300
subjects
(MRI-PDFF)
880
subjects
(MRE)
Quantitative Imaging Analysis for NAFLD and NASH
Our study teams provide quantitative imaging analyses for liver disorders such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), with liver endpoint measurements including hepatic fat, stiffness and fibrosis.
Magnetic resonance imaging – proton density fat fraction (MRI-PDFF) provides a reliable assessment of fat across the entire liver.
Magnetic resonance elastography (MRE) measures liver tissue stiffness by combining MRI imaging with sound waves.
DOWNLOAD OUR ADVANCED LIVER IMAGING SELL SHEET AND INFOGRAPHIC
GENERAL INQUIRIES:
Toll-Free: 1.877.267.3324
Local: 1.301.214.7600
Fax: 1.301.214.7601
BTRinfo@gobio.com
BUSINESS DEVELOPMENT:
Local: 1.301.214.7628
BTRbusiness@gobio.com
CLINICAL TRIALS SUPPORT:
Toll Free: 1.877.324.8326
BTRsupport@gobio.com
MID-ATLANTIC:
One Preserve Parkway
Suite 600
Rockville, MD 20852
USA
NORTHEAST:
155 Corporate Woods
Suite 180
Rochester, NY 14623
USA
WEST COAST:
400 Oyster Point Blvd
Suite 339
South San Francisco, CA 94080
USA
EUROPE:
Building 3 Chiswick Park
Suite 258
566 Chiswick High Road
London, W4 5YA
UK
Connect with Us for the latest on our clinical trials services, including medical imaging and cardiac safety testing